DJIA 17,001.22 -38.27 -0.22%
NASDAQ 4,538.55 6.45 0.14%
S&P 500 1,988.40 -3.97 -0.20%
market minute promo

Allergan, Inc. (NYSE: AGN)

165.56 1.18 (0.72%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AGN $165.56 0.72%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $163.50
Previous Close $164.38
Daily Range $162.14 - $166.58
52-Week Range $86.95 - $174.49
Market Cap $49.2B
P/E Ratio 37.70
Dividend (Yield) $0.20 (0.1%)
Ex-Dividend Date
Dividend Pay Date
08/13/14
09/05/14
Volume 1,558,929
Average Daily Volume 2,335,676
Current FY EPS $5.79

Sector

Healthcare

Industry

Drugs

Allergan, Inc. (AGN) Description

A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc. Website: http://www.allergan.com/

News & Commentary

California Judge Derails Allergan's Attempt to Block Ackman and Valeant

Judge David Carter opted against moving up Allergan's suit against Valeant and Pershing Square, potentially clearing the way for a special meeting that could replace members of Allegan's board by year end.

Eli Lilly Uncovers Positive Data from Ixekizumab Studies - Analyst Blog

AstraZeneca Updates on PLATO Study Investigation on Brilinta - Analyst Blog

How Will Allergan (AGN) Stock Respond To Special Shareholders Meeting Request By Valeant (VRX), Pers

How Will Allergan (AGN) Stock Respond To Special Shareholders Meeting Request By Valeant (VRX), Pershing Square?

In the news: Qualcomm wants to end China probe, Apple's supply issues and more

Why Allergan (AGN) Stock Is Lower Today

Wall Street Breakfast: Restrictions Imposed On Citigroup's Hedge Fund Sales

GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA - Analyst Blog

GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA - Analyst Blog

Sanofi's (SNY) Cerdelga FDA Approved for Gaucher Disease - Analyst Blog

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog

See More AGN News...

AGN's Top Competitors

AGN $165.56 (0.72%)
Current stock: AGN
JNJ $103.10 (-0.38%)
Current stock: JNJ
NVS $88.95 (0.00%)
Current stock: NVS
RHHBY $36.32 (-0.33%)
Current stock: RHHBY